• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 引发的固有免疫反应的逃逸和过度激活:一枚硬币的两面。

Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.

机构信息

Department of Bioactive Material Science, Korea Zoonosis Research Institute and Genetic Engineering Research Institute, Jeonbuk National University, Jeonju 54531, Korea.

Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.

出版信息

Viruses. 2022 Mar 4;14(3):530. doi: 10.3390/v14030530.

DOI:10.3390/v14030530
PMID:35336937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8951629/
Abstract

In the past 20 years, coronaviruses (CoVs), including SARS-CoV-1, MERS-CoV, and SARS-CoV-2, have rapidly evolved and emerged in the human population. The innate immune system is the first line of defense against invading pathogens. Multiple host cellular receptors can trigger the innate immune system to eliminate invading pathogens. However, these CoVs have acquired strategies to evade innate immune responses by avoiding recognition by host sensors, leading to impaired interferon (IFN) production and antagonizing of the IFN signaling pathways. In contrast, the dysregulated induction of inflammasomes, leading to uncontrolled production of IL-1 family cytokines (IL-1β and IL-18) and pyroptosis, has been associated with COVID-19 pathogenesis. This review summarizes innate immune evasion strategies employed by SARS-CoV-1 and MERS-CoV in brief and SARS-CoV-2 in more detail. In addition, we outline potential mechanisms of inflammasome activation and evasion and their impact on disease prognosis.

摘要

在过去的 20 年中,冠状病毒(CoV),包括 SARS-CoV-1、MERS-CoV 和 SARS-CoV-2,在人类中迅速进化和出现。先天免疫系统是抵御入侵病原体的第一道防线。多种宿主细胞受体可以触发先天免疫系统来消除入侵的病原体。然而,这些 CoV 通过避免被宿主传感器识别而获得了逃避先天免疫反应的策略,导致干扰素(IFN)产生受损和 IFN 信号通路受到拮抗。相比之下,细胞焦亡相关的炎性小体的失调诱导,导致白细胞介素(IL)-1 家族细胞因子(IL-1β 和 IL-18)和细胞焦亡的不受控制产生,与 COVID-19 的发病机制有关。本综述简要总结了 SARS-CoV-1 和 MERS-CoV 采用的先天免疫逃避策略,并更详细地介绍了 SARS-CoV-2 的策略。此外,我们还概述了炎性小体激活和逃避的潜在机制及其对疾病预后的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/757238eb2b6d/viruses-14-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/15faa914fc0f/viruses-14-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/3e3c5a09e74c/viruses-14-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/757238eb2b6d/viruses-14-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/15faa914fc0f/viruses-14-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/3e3c5a09e74c/viruses-14-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf1b/8951629/757238eb2b6d/viruses-14-00530-g003.jpg

相似文献

1
Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.SARS-CoV-2 引发的固有免疫反应的逃逸和过度激活:一枚硬币的两面。
Viruses. 2022 Mar 4;14(3):530. doi: 10.3390/v14030530.
2
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.冠状病毒:先天免疫、炎症小体激活、炎症细胞死亡和细胞因子。
Trends Immunol. 2020 Dec;41(12):1083-1099. doi: 10.1016/j.it.2020.10.005. Epub 2020 Oct 15.
3
Coronavirus virulence genes with main focus on SARS-CoV envelope gene.主要聚焦于严重急性呼吸综合征冠状病毒包膜基因的冠状病毒毒力基因。
Virus Res. 2014 Dec 19;194:124-37. doi: 10.1016/j.virusres.2014.07.024. Epub 2014 Aug 2.
4
An Update on Innate Immune Responses during SARS-CoV-2 Infection.关于 SARS-CoV-2 感染期间固有免疫反应的最新研究进展。
Viruses. 2021 Oct 14;13(10):2060. doi: 10.3390/v13102060.
5
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.SARS-CoV-2 介导的抗病毒干扰素途径的逃逸策略。
J Microbiol. 2022 Mar;60(3):290-299. doi: 10.1007/s12275-022-1525-1. Epub 2022 Feb 5.
6
Innate immune sensing of coronavirus and viral evasion strategies.先天免疫感知冠状病毒和病毒逃避策略。
Exp Mol Med. 2021 May;53(5):723-736. doi: 10.1038/s12276-021-00602-1. Epub 2021 May 6.
7
Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.SARS-CoV-2 的先天免疫逃避:与 SARS-CoV 的比较。
Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2135. Epub 2020 Jul 30.
8
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.严重急性呼吸综合征冠状病毒 2 型和其他冠状病毒对固有免疫激活的控制。
J Interferon Cytokine Res. 2021 Jun;41(6):205-219. doi: 10.1089/jir.2021.0060.
9
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.SARS-CoV-2 感染期间的先天免疫反应和炎症小体激活。
Inflammation. 2022 Oct;45(5):1849-1863. doi: 10.1007/s10753-022-01651-y. Epub 2022 Aug 11.
10
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.宿主与 SARS-CoV-2 的较量:固有免疫与病毒逃逸策略。
Mol Ther. 2022 May 4;30(5):1869-1884. doi: 10.1016/j.ymthe.2022.02.014. Epub 2022 Feb 14.

引用本文的文献

1
Dynamics of Innate Immunity in SARS-CoV-2 Infections: Exploring the Impact of Natural Killer Cells, Inflammatory Responses, Viral Evasion Strategies, and Severity.新型冠状病毒感染中固有免疫的动力学:探究自然杀伤细胞、炎症反应、病毒逃避策略及疾病严重程度的影响
Cells. 2025 May 22;14(11):763. doi: 10.3390/cells14110763.
2
Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant.感染新冠病毒德尔塔变异株的存活患者与非存活患者之间差异表达的转录组分析。
Sci Rep. 2025 May 15;15(1):16844. doi: 10.1038/s41598-025-00280-3.
3
Modulating oxidative stress: a reliable strategy for coping with community-acquired pneumonia in older adults.

本文引用的文献

1
T cell responses to SARS-CoV-2 in humans and animals.人类和动物对 SARS-CoV-2 的 T 细胞反应。
J Microbiol. 2022 Mar;60(3):276-289. doi: 10.1007/s12275-022-1624-z. Epub 2022 Feb 14.
2
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.SARS-CoV-2 病毒蛋白 3a 通过编码的 viroporin 触发 NLRP3 炎症途径。
Virology. 2022 Mar;568:13-22. doi: 10.1016/j.virol.2022.01.003. Epub 2022 Jan 17.
3
A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization.一种有前景的 COVID-19 疫苗接种策略:异源免疫。
调节氧化应激:应对老年人社区获得性肺炎的可靠策略。
Front Med (Lausanne). 2025 Mar 26;12:1549658. doi: 10.3389/fmed.2025.1549658. eCollection 2025.
4
Mucosal immunity in COVID-19: a comprehensive review.COVID-19 中的黏膜免疫:全面综述。
Front Immunol. 2024 Aug 14;15:1433452. doi: 10.3389/fimmu.2024.1433452. eCollection 2024.
5
Protection against Severe Illness versus Immunity-Redefining Vaccine Effectiveness in the Aftermath of COVID-19.预防重症与免疫——重新定义新冠疫情后的疫苗效力
Microorganisms. 2023 Jul 31;11(8):1963. doi: 10.3390/microorganisms11081963.
6
Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses.源自口蹄疫病毒基因组的非编码 RNA 触发针对冠状病毒的广泛抗病毒活性。
Front Immunol. 2023 Mar 29;14:1166725. doi: 10.3389/fimmu.2023.1166725. eCollection 2023.
7
SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)编码的小RNA能够抑制宿主细胞中SERINC5的表达,以促进病毒复制。
Front Microbiol. 2023 Feb 16;14:1066493. doi: 10.3389/fmicb.2023.1066493. eCollection 2023.
8
Laboratory Findings and Clinical Outcomes of ICU-admitted COVID-19 Patients: A Retrospective Assessment of Particularities Identified among Romanian Minorities.入住重症监护病房的新冠病毒肺炎患者的实验室检查结果及临床结局:对罗马尼亚少数民族中发现的特殊性进行的回顾性评估
J Pers Med. 2023 Jan 21;13(2):195. doi: 10.3390/jpm13020195.
9
Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.表观遗传学在新冠病毒感染过程中影响宿主免疫中的作用。
Biochim Biophys Acta Mol Basis Dis. 2023 Mar;1869(3):166634. doi: 10.1016/j.bbadis.2022.166634. Epub 2022 Dec 26.
10
Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2-host protein-protein interaction network.通过探测 SARS-CoV-2 宿主蛋白-蛋白相互作用网络发现宿主定向的病毒感染调节剂。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac456.
J Microbiol Biotechnol. 2021 Dec 28;31(12):1601-1614. doi: 10.4014/jmb.2111.11026.
4
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.SARS-CoV-2 通过靶向 STAT1-IRF1-NLRC5 轴抑制 MHC Ⅰ类途径的诱导。
Nat Commun. 2021 Nov 15;12(1):6602. doi: 10.1038/s41467-021-26910-8.
5
The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the order.该目下冠状病毒及其他病毒的分类学、宿主范围和致病性。
Anim Dis. 2021;1(1):5. doi: 10.1186/s44149-021-00005-9. Epub 2021 Apr 23.
6
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.一种茎环 RNA RIG-I 激动剂可预防小鼠急性和慢性 SARS-CoV-2 感染。
J Exp Med. 2022 Jan 3;219(1). doi: 10.1084/jem.20211818. Epub 2021 Nov 10.
7
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response.SARS-CoV-2 核衣壳蛋白在调节固有免疫反应中的双重作用。
Signal Transduct Target Ther. 2021 Sep 1;6(1):331. doi: 10.1038/s41392-021-00742-w.
8
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.SARS-CoV-2 N 蛋白靶向 TRIM25 介导的 RIG-I 激活以抑制先天免疫。
Viruses. 2021 Jul 23;13(8):1439. doi: 10.3390/v13081439.
9
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.约 1%的 60 岁以下患有危及生命的 COVID-19 的男性存在 X 连锁隐性 TLR7 缺陷。
Sci Immunol. 2021 Aug 19;6(62). doi: 10.1126/sciimmunol.abl4348.
10
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.SARS-CoV-2 N 蛋白促进 NLRP3 炎性小体激活诱导过度炎症。
Nat Commun. 2021 Aug 2;12(1):4664. doi: 10.1038/s41467-021-25015-6.